Display options
Share it on

Clin Rheumatol. 1984 Mar;3:39-50. doi: 10.1007/BF03342621.

Auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Cooperative systematic studies of rheumatic diseases.

Clinical rheumatology

H J Williams, J R Ward, M J Egger, J C Reading, C O Samuelson, M Altz-Smith, R W Willkens, M A Solsky, S P Hayes, D Furst

PMID: 6432412 DOI: 10.1007/BF03342621

Abstract

Two hundred eight patients were studied in a prospective, controlled, double-blind multicenter trial comparing auranofin (AUR), gold sodium thiomalate (GST), and placebo. One hundred sixty-one patients completed at least 20 weeks of therapy. Response to a variety of measures of efficacy was generally modest for both gold treatment groups although improvement was continuing in both groups at the end of the study. There was statistically significant improvement with both gold preparations compared to placebo for the number of tender joints, the joint tenderness score, and physician assessment of disease severity. GST was also significantly better than placebo for the joint swelling score. GST demonstrated more improvement in patients with anemia and thrombocytosis compared to the other treatment groups and both gold preparations were superior to placebo in improvement of an elevated erythrocyte sedimentation rate. Twenty-seven percent of patients on GST were withdrawn from the study for adverse drug reaction with rash and stomatitis being the predominant cause. Only 6% of patients on AUR were withdrawn for untoward drug effect. The time of onset of the adverse reactions is discussed. The two gold preparations were similar in efficacy although AUR was better tolerated.

Cited by

References

  1. Ann Intern Med. 1981 Aug;95(2):178-81 - PubMed
  2. J Rheumatol Suppl. 1982 Jul-Aug;8:173-8 - PubMed
  3. Bull Rheum Dis. 1976-1977;27(7):912-7 - PubMed
  4. Arthritis Rheum. 1974 Nov-Dec;17(6):964-8 - PubMed
  5. Bull Rheum Dis. 1958 Dec;9(4):175-6 - PubMed
  6. Arthritis Rheum. 1970 Nov-Dec;13(6):812-25 - PubMed
  7. N Engl J Med. 1976 Apr 22;294(17):919-21 - PubMed
  8. J Rheumatol Suppl. 1982 Jul-Aug;8:154-9 - PubMed
  9. Arthritis Rheum. 1979 Feb;22(2):105-10 - PubMed
  10. J Am Med Assoc. 1949 Jun 25;140(8):659-62 - PubMed
  11. J Rheumatol Suppl. 1982 Jul-Aug;8:184-9 - PubMed
  12. Arch Dermatol. 1974 Mar;109(3):372-6 - PubMed
  13. Ann Rheum Dis. 1976 Apr;35(2):138-42 - PubMed
  14. Arthritis Rheum. 1983 Nov;26(11):1303-15 - PubMed
  15. J Rheumatol Suppl. 1982 Jul-Aug;8:190-6 - PubMed
  16. Arthritis Rheum. 1973 May-Jun;16(3):353-8 - PubMed
  17. Am J Med. 1983 Dec 30;75(6A):133-7 - PubMed
  18. J Rheumatol. 1977 Autumn;4(3):252-60 - PubMed
  19. Ann Intern Med. 1977 Dec;87(6):717-9 - PubMed
  20. Arthritis Rheum. 1979 May;22(5):495-501 - PubMed
  21. Ann Intern Med. 1974 Jan;80(1):21-6 - PubMed
  22. J Rheumatol Suppl. 1982 Jul-Aug;8:179-83 - PubMed
  23. J Rheumatol. 1976 Mar;3(1):21-6 - PubMed
  24. J Rheumatol. 1978 Spring;5(1):68-74 - PubMed
  25. Arthritis Rheum. 1965 Apr;8:302-34 - PubMed
  26. Ann Rheum Dis. 1960 Jun;19:95-119 - PubMed
  27. Arthritis Rheum. 1977 Jul-Aug;20(6):1188-91 - PubMed

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources